This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
partially because its key riskfactor, high blood pressure, is a ‘silent killer,’ and most patients have no symptoms before their first heart attack or stroke. Eighty percent of heart attacks and strokes are preventable. Yet, CVD remains the leading cause of death in the U.S.,
Caristo Diagnostics Limited has announced the results of a landmark clinical study published in The Lancet that support the ability of Caristo's CaRi-Heart AI technology to quantify coronary artery inflammation and accurately predict cardiac events. fold higher risk for cardiac mortality and 5.5-fold
Recently, the use of assisted reproductive technology (ART) has rapidly increased. Moreover, emerging evidence suggests an increased risk of cardiovascular disease (CVD) in offspring conceived using ART. As a result, an increasing number of people are concerned about the safety of offspring produced through ART.
In the age of technology, wearable devices have revolutionized how we approach health and wellness. This blog explores the ways wearable technology can help track heart health, the advantages it offers, and how it contributes to better outcomes for those requiring surgical intervention.
Background:Infertility treatment with assisted reproductive technologies (ART) has been associated with adverse vascular events in some, but not all previous studies. Endothelial damage, prothrombotic factor release, and a higher prevalence of cardiovascular riskfactors in those receiving ART have been invoked to explain this association.
Heart disease remains one of the leading causes of death worldwide, often attributed to a mix of lifestyle choices, environmental factors, and genetic predispositions. This blog explores how genetics influence heart health and whether mitigating these inherited risks is possible. Can You Prevent Heart Disease if Its in Your Genes?
The FDA’s Breakthrough Device Designation is granted for technologies that have the possibility to encourage more effective diagnosis or treatment for life-threatening or irreversibly debilitating diseases. Cleerly is committed to accelerating the availability of its technology to healthcare providers and patients alike.
Advancements in technology over the decades have elevated research from early candidate gene studies to present-day genome-wide scans, unveiling numerous genetic and epigenetic riskfactors for AUD. We review progress in understanding the genetics and epigenetics of AUD, summarizing the key findings.
The use of assisted reproductive technology (ART) is growing, both to assist individuals with infertility and for fertility preservation. Individuals with cardiovascular disease (CVD), or riskfactors for CVD, are increasingly using ART. Circulation, Ahead of Print.
However, the prevalent use of TAVR on a diverse patient profile with different riskfactors, such as peripheral artery disease, precluded the possibility of a transfemoral approach despite the improvement of valves and delivery systems technology.
The company reports this broadens the use of the novel bioadaptor platform technology beyond the treatment of coronary artery disease. The DynamX Bioadaptor platform is a medical technology designed to establish the new standard of care for vascular interventions, according to a written statement on the designation. Glob Heart.
This is the first PFA technology to receive FDA approval and follows the recent European CE (Conformité Européenne) Mark of the PulseSelect PFA system in November. This is the first PFA technology to receive FDA approval and follows the recent European CE (Conformité Européenne) Mark of the PulseSelect PFA system in November.
However, conversations are ongoing around best practices and standards of care regarding contrast management and treatment for those with higher riskfactors, like compromised renal function. Review riskfactors determining higher risk populations. Click here to learn more or register for the webinar.
In organ transplantation, an extended criteria donor is defined as having perceived riskfactors linked to poor subsequent outcomes, for example, those with age >55 or ischemic times exceeding 4 hours, which sometimes leads to rejection of the donor organ.
Here’s what you can expect at the biggest conference in cardiorenal metabolic health, the 19th Annual Cardiometabolic Congress (CMHC), DECODING THE CONSTELLATION of Cardiometabolic Health and RiskFactors. Learn more or secure your registration by clicking here.
Introduction:Infertility treatment with assisted reproductive technologies (ART) has previously been associated with adverse vascular events in some, but not all studies. Stroke, Volume 55, Issue Suppl_1 , Page A11-A11, February 1, 2024.
The primary outcome is the mean difference between the intervention versus control groups in distance walked on the 6‐minute walk test (ie, functional capacity) at 12 weeks post randomization.
In an original investigation presented at the Cardiology Research Technology conference in Washington, D.C. Even with advances in stent technology, patients with coronary in-stent restenosis continue to comprise approximately 10 percent of individuals undergoing angioplasty interventions each year. and Susan F.
We know that how much AF a patient experiences matters, but we dont know how different durations or patterns impact the risk of future health events. Combining continuous rhythm monitoring with traditional riskfactors has helped clarify how AF burden and patterns can inform risk, prioritization, and treatment decisions, said Jonathan P.
These patients also faced a 65% higher mortality rate, even after adjusting for traditional riskfactors. These findings underscore the power of AI-ECG in identifying patients at a significantly higher risk of MACE and mortality, even when traditional markers like left ventricular ejection fraction appear normal. Nicholas S.
Cardiorenal and metabolic diseases represent a complex constellation of lifestyle factors and health conditions that significantly impact longevity and quality of life. In the United States alone, an estimated 47 million people are affected by cardiorenal metabolic-related riskfactors and diseases. What are omics technologies?
Family Medicine Specialists' implementation of Cardio Diagnostics' tests in their patient population with CHD riskfactors demonstrates the first time a risk-bearing provider is leveraging precision epigenetics-based heart disease technologies with a population health intelligence tool to optimize risk-sharing contracts.
mtaschetta-millane Thu, 07/18/2024 - 09:19 July 18, 2024 — Elucid , a pioneering AI medical technology company providing physicians with imaging analysis software based on ground truth histology to support diagnosis and treatment of cardiovascular disease, has initiated site recruitment for its Plaque as a RiskFactor for Evaluation of Vascular Events (..)
The study, “Comprehensive Cardiovascular RiskFactor Control with a Mobile Health Cardiovascular Risk Self-Management Program,” highlights the potential use of digital health technology in the comprehensive control of riskfactors for cardiovascular disease (CVD), the leading cause of death and disability in the United States.
Understanding Cardiovascular Disease in Women Understanding cardiovascular disease in women involves recognizing unique riskfactors such as hormonal changes and pregnancy-related complications, necessitating proactive care and awareness to manage and prevent heart disease effectively.
We will use modern technologies to explore the great number of chemicals in the food supply. Blood lipids such as cholesterol and triglycerides are causal riskfactors for coronary heart disease as well as several other types of cardiovascular disease , such as aortic stenosis).
For PAD, the clot-sensing technology is being developed to instantly identify fresh clot and differentiate it from organized clot thrombus poor in RBCs as well as plaque, calcium and other tissue in real-time to inform individualized PAD treatment. we aspirate, dissolve the clot, or use another method?
This is driven by the aging of our populations, the growing prevalence of AF riskfactors and by the proliferation of longer-term electrocardiographic monitoring, including patient-facing technologies 1,2. We are diagnosing atrial fibrillation (AF) more often that at any time in history.
mtaschetta-millane Thu, 07/25/2024 - 08:55 July 25, 2024 — Nanox, an innovative medical imaging technology company, announced that the AI Cardiac Solution (HealthCCSng) of its subsidiary, Nanox.AI Such an approach may be used to identify higher risk individuals and screen patients for future clinical trials.
However, conversations are ongoing around best practices and standards of care regarding contrast management and treatment for those with higher riskfactors, like compromised renal function. Review riskfactors determining higher risk populations. Click here to learn more or register for the webinar.
That is why Quer, in collaboration with iRhythm Technologies (the maker of a wearable electrocardiogram patch called the ZioXT ), set out to find other patterns in the ECG data of people with AFib. “We But even over a two-week span, people with very occasional AFib may not have an episode picked up by this device.
After the AI model reviewed patterns in electrocardiogram readings as well as patient characteristics, investigators were able to determine riskfactors for both types of sudden cardiac arrest.
National and international cardiac organisations recommend all patients use this technology, however patient engagement is suboptimal. Introduction Cardiac implantable electronic devices (CIED) can transfer data to the healthcare team, remotely. A sample size of 100 will have a 90% power to detect a minimum difference of 1.07
Among patients with intracranial stenosis, those with hemodynamic compromise are at high risk for recurrent stroke despite medical therapy and riskfactor modification.
Likelihood of CAD can be estimated based on symptoms and riskfactors, and an abnormal ECG may also be helpful. 1 2 The steady thump of patients’ feet on the treadmill has instead been replaced by scanner-based technologies.
At the forefront of this quest lie the remarkable advancements in imaging technology, ushering in a new era of precision and insight. Cardiovascular Insights: Unveiling Hidden Risks Cardiovascular diseases remain a leading cause of mortality globally, underscoring the critical importance of early detection and risk assessment.
At the forefront of this quest lie the remarkable advancements in imaging technology, ushering in a new era of precision and insight. Cardiovascular Insights: Unveiling Hidden Risks Cardiovascular diseases remain a leading cause of mortality globally, underscoring the critical importance of early detection and risk assessment.
On World Heart Day, cardiologists can make a significant impact by: Spreading Awareness: They can educate the public about the riskfactors and warning signs of heart diseases. Encouraging individuals to schedule regular check-ups can help identify riskfactors early and prevent the development of heart diseases.
The report identifies several pathways to begin to narrow the gap, including: Expanding women-focused research, accelerating translation of findings and facilitating the commercialization of products and technologies to improve women's health.
The risk of death is extremely low (0.05-0.1%). Technological innovations have made catheter ablation safer and more effective than ever before,” Tzeis, who added, “For example, we now have pulsed field ablation which uses high energy electrical pulses to treat atrial fibrillation without damaging the nerves or oesophagus. Eur Heart J.
2,3 Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib.4 Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of riskfactors: cohort study based on longitudinal data from the Framingham Heart Study. Epidemiology of Atrial Fibrillation in the 21st Century.
Recent technological advancements, such as catheter design and energy delivery, can pave the way for the wider adoption of PFA in clinical practice to improve patient outcomes. Journal of American Medical Association, 2001; 285:2370- 2370. doi:10.1001/jama.285.18.2370 285.18.2370 2 Andrade JG.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content